Kikuchi, Yoshinori http://orcid.org/0000-0001-6070-6927
Shimada, Hideaki
Yamasaki, Fumiyuki
Yamashita, Taku
Araki, Koji
Horimoto, Kohei
Yajima, Satoshi
Yashiro, Masakazu
Yokoi, Keigo
Cho, Haruhiko
Ehira, Takuya
Nakahara, Kazunari
Yasuda, Hiroshi
Isobe, Kazutoshi
Hayashida, Tetsu
Hatakeyama, Shingo
Akakura, Koichiro
Aoki, Daisuke
Nomura, Hiroyuki
Tada, Yuji
Yoshimatsu, Yuki
Miyachi, Hayato
Takebayashi, Chiaki
Hanamura, Ichiro
Takahashi, Hiroyuki
Article History
Received: 31 January 2024
Accepted: 21 February 2024
First Online: 17 March 2024
Declarations
:
: Dr. Kikuchi received lecture fees from Teijin Pharma Ltd. Dr. Hayashida received lecture fees from Pfizer Japan Inc., Eli Lilly Japan K.K., received a research grant from Eli Lilly Japan K.K. Dr. Aoki received lecture fees from Merck & Co., Inc. Dr. Miyachi serves as a consultant to BML Inc. and SRL, Inc. Dr. Takebayashi received lecture fees from Chugai Pharmaceutical Co., Ltd, Kyowa Kirin Co., Ltd., AstraZeneca K.K, Nippon Shinyaku Co., Ltd., Meiji Yakuhin Co., Ltd., SymBio Pharmaceuticals Limited., AbbVie GK, Takeda Pharmaceutical Co., Ltd, Janssen Pharmaceutical K.K., Daiichi Sankyo Co., Ltd., Amgen Inc., Nippon Kayaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd. and Merck & Co. Inc., received a manuscript fee from Chugai Pharmaceutical Co., Ltd. Dr. Miyachi serves as a consultant to BML Inc. and SRL, Inc. Other Shimada, Yamasaki, Yamashita, Araki, Horimoto, Yajima, Yashiro, Yokoi, Chou, Ehira, Nakahara, Yasuda, Isobe, Hatakeyama, Akakura, Nomura, Tada, Yoshimatsu, Hanamura and Takahashi have no conflicts of interest.